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Abstract 10 
 11 
The disproportionate prevalence of human immunodeficiency virus (HIV) in sub-12 
Saharan Africa, recognition of the T-helper (Th)1/Th2 immunological 13 
dichotomy, and geographical co-prevalence of helminths and HIV, led to the 14 
hypothesis that helminthiasis increases susceptibility to HIV. Recently-published 15 
data from Tanzania suggests infection with filariasis doubles an individual’s risk 16 
of HIV acquisition.  17 
 18 
 19 
Main text 20 
 21 
By 2015, an estimated 25.5 million people in Sub-Saharan Africa were living with 22 
HIV, accounting for 71% of the global burden 23 
(http://www.unaids.org/en/resources/fact-sheet). The relationship between 24 
helminths and HIV has been studied extensively with conflicting reports on the 25 
effect of different helminth species. Kroidl et al recently published a carefully 26 
conducted observational study reporting an increased risk of HIV infection in 27 
Wuchereria bancrofti infected individuals residing in southwest Tanzania [1]. 28 
This observation is the first evidence supporting the hypothesis W. bancrofti 29 
infection plays a role in HIV acquisition. 30 
 31 
Lymphatic filariasis (LF) is caused by the nematode species Wuchereria 32 
bancrofti, Brugia malayi, or Brugia timori depending on geographic location. 33 
Previous studies on W. bancrofti and HIV prevalence have shown no association 34 
with prevalence of LF infection, circulating filarial antigen (CFA) levels or 35 
response to anti filarial treatment [2-4]. However, in vitro experimentation using 36 
peripheral blood mononuclear cells (PBMC) from patients with filarial infections 37 
showed that cells from persons with W. bancrofti infections exhibited enhanced 38 
susceptibility to HIV-1 infection compared to cells from individuals without 39 
filariasis [5].  40 
 41 
Kroidl et al [1] present data from the Surveillance of Lymphatic Filariasis (SOLF) 42 
cohort-study, a prospective observational study in which they were able to 43 
determine the incidence of HIV infection in individuals with or without 44 
lymphatic filariasis. Five annual surveys were performed where blood, urine, 45 
stool and sputum were collected together with data on sociodemographic and 46 
behavioural factors. 47 
 48 
Circulating filarial antigen (CFA) testing was performed on 2699 stored serum 49 
samples.  Individuals underwent contemporaneous HIV testing. The overall 50 
prevalence of lymphatic filariasis infection was 26% (691 / 2673). Individuals 51 
found to be HIV positive at enrolment and children under the age of fourteen 52 
were excluded from analysis leaving 1055 individuals with 2626 person years of 53 
observation for the final analysis. HIV seroconversion events were identified in 54 
44 participants >14 years of age.  55 
 56 
HIV incidence was 0.80 cases per 100 person-years in those without lymphatic 57 
filariasis compared with 1.91 cases per 100 person-years in those with 58 
lymphatic filariasis. When adjusted for sex, age and socioeconomic status this 59 
suggests a 2.17 times increased risk of HIV infection in individuals infected with 60 
W. bancrofti compared with uninfected participants [adjusted incidence rate 61 
ratio (aIRR) 2.17, 95% confidence interval (CI) 1.08–4.37, p=0.0300]. 62 
Adolescents and young adults (aged 14-24) seemed to be unusually affected by 63 
W. bancrofti co-infection, (risk ratio 3.16, 95% CI 0.53 – 2.17, p=0.075), but this 64 
sub-group experienced only seven HIV infections, so the finding must be 65 
interpreted with caution. 66 
 67 
Multiple binomial regression models were constructed, each including lymphatic 68 
filariasis and age plus one potential confounding risk factor associated with HIV 69 
infection. Having a HIV positive partner, having more than one sex partner and 70 
being divorced or separated had significant association with HIV incidence but 71 
lymphatic filariasis remained a stable risk factor throughout.  No data is available 72 
on the existence of concomitant sexually transmitted infections – a key risk 73 
factor for HIV acquisition.. However, the fact that the effect estimate changed 74 
very little when relevant behavioural risk factors were included in the model 75 
provides reassurance. 76 
 77 
No significant effect on HIV incidence was seen for individuals who had ever 78 
experienced haematuria or ever had Schistosoma haematobium (measured by 79 
microscopic examination of urine) but it is not clear that the timing of these 80 
exposures coincided with HIV exposure within the cohort. Similarly, no 81 
association was observed for any intestinal nematode (Trichuris, Ascaris or 82 
hookworm on Kato Katz examination of stool). Why then should lymphatic 83 
filariasis have a unique effect?  Perhaps this systemic helminth infection, with 84 
constantly circulating microfilariae, compared with intestinal infections (albeit 85 
with transient larval migration in some species), more potently induces immune 86 
changes such as increased expression of HIV co-receptors CCR5 and CXCR4 on T 87 
cells, or Th2-mediated suppression of the Th1 biased antiviral immune 88 
responses, and hence HIV acquisition [6]. 89 
 90 
Like lymphatic filariasis, the systemic helminth infection Schistosoma mansoni is 91 
recognized to have profound immunomodulatory effects in humans: S. mansoni 92 
might therefore be expected to have a similar effect.  Some epidemiological 93 
studies have described an association between S. mansoni and HIV infection 94 
prevalence.  However, a recent prospective matched case–control study 95 
examining HIV incidence performed in endemic communities around Lake 96 
Victoria found that S. mansoni infection was not associated with HIV acquisition 97 
[7]. In macaque studies, S. mansoni infection enhanced simian HIV acquisition by 98 
rectal challenge but not by intravenous inoculation, suggesting that physical 99 
lesions in the mucosa play a key role in HIV acquisition for schistosomiasis [8].  100 
 101 
In keeping with this, S. haematobium is recognized as a cause of mucosal damage 102 
to the female genital tract and these lesions are hypothesized to increase HIV 103 
susceptibility. S. haematobium infection in women has been identified as 104 
associated with HIV infection in observational studies performed in Zimbabwe 105 
and Mozambique [9,10]; having S. haematobium or living in a highly endemic 106 
area appeared to increase the risk of HIV infection approximately 3 fold. To date 107 
there are no published prospective or interventional trials examining this key 108 
hypothesis, or demonstrating a benefit of schistosomiasis control for HIV 109 
incidence.  110 
 111 
Kroidl et al suggest that infection with W. bancrofti more than doubles the risk of 112 
HIV acquisition and that this must prompt consideration of interventional trials 113 
evaluating the effect of antifilarial treatment on HIV incidence. Such studies 114 
would need detailed ethical consideration.  Planning would need to take into 115 
account recent changes in HIV prevention policy which encourage HIV test-and-116 
treat, especially for high HIV-risk populations.  These policies may substantially 117 
reduce HIV incidence. But, as an extension of Kroidl’s suggestion, it would 118 
certainly be of interest to include an investigation of HIV incidence into large-119 
scale implementation trials comparing the effectiveness of mass drug 120 
administration with current, microfilaricidal regimens (such as ivermectin and 121 
albendazole) with new strategies including macrofilaricidal agents (such as 122 
doxycycline) which are expected to reduce the filarial burden more rapidly.  As 123 
well, nested studies could explore effects on immunological parameters 124 
hypothesised to mediate effects of filariasis on HIV acquisition. Ultimately, 125 
control of lymphatic filariaisis is necessary to public health in its own right, and 126 
must be pursued. 127 
 128 
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